AWM
ALNY icon

Activest Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Activest Wealth Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.62K Buy
22
+21
+2,100% +$6.33K ﹤0.01% 668
2026
Q1 		$331 Sell
1
-107
-99% -$36.4K ﹤0.01% 1103
2025
Q4 		$42.9K Buy
108
+107
+10,700% +$47.4K 0.01% 347
2025
Q3 		$456 Hold
1
– – ﹤0.01% 967
2025
Q2 		$326 Buy
+1
New +$277 ﹤0.01% 922
2025
Q1 		– Sell
-1
Closed -$257 – 1054
2024
Q4 		$235 Buy
+1
New +$263 ﹤0.01% 621

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Activest Wealth Management's ALNY Position: Q2 2026 in Review

Activest Wealth Management increased its Alnylam Pharmaceuticals (ALNY) stake by 2,100% in Q2 2026, buying an estimated $6.33K and bringing the position to 22 shares worth $6.62K. The position accounts for ﹤0.01% of the portfolio, ranked #668.

Activest Wealth Management first reported a position in ALNY in Q4 2024 and has held it in 6 quarters since. The position peaked at $42.9K in Q4 2025. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Activest Wealth Management held 22 shares of Alnylam Pharmaceuticals worth $6.62K as of Q2 2026.
  • Activest Wealth Management bought 21 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $6.33K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #668 holding.
  • Activest Wealth Management first reported a position in Alnylam Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Activest Wealth Management's Alnylam Pharmaceuticals position peaked at $42.9K in Q4 2025.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.